BACKGROUND AND OBJECTIVE To examine the outcomes of vitrectomy in ocular trauma with opaque cornea. PATIENTS AND METHODS This retrospective study included 17 eyes of 16 patients who underwent vitrectomy with temporary keratoprosthesis or endoscopy at Walter Reed Army Medical Center, Washington, DC, from March 2003 to October 2010. RESULTS A temporary keratoprosthesis was used in 8 eyes (47%...

PURPOSE To conduct a cost-utility analysis and determine the cost-effectiveness of the Boston Keratoprosthesis (Boston Kpro). DESIGN Retrospective cohort study. METHODS setting: The Massachusetts Eye and Ear Infirmary corneal service. patients: Inclusion required a minimum 2-year follow-up. Patients with autoimmune diseases and chemical burns were excluded. Eighty-two patients were included...

Objective To describe a case of severe chemical burn treated with novel Boston type I keratoprosthesis (B1-KPro) technique. Methods We present the 25-year-old woman poor light perception in both eyes who had bilateral caustic soda 3 months earlier. She underwent several amniotic membrane implants and subconjunctival triamcinolone injections without significant improvement. decided to perform tw...

purpose: to report confocal scan features of keratic precipitates (kps) in fuchs’ heterochromic iridocyclitis (fhic). methods: in this descriptive study, corneal confocal scan was performed to characterize kps in patients with fhic referred to labbafinejad medical center from november 2005 to march 2007. polymerase chain reaction (pcr) for herpes simplex virus, herpes zoster virus, toxoplasma g...

OBJECTIVE To develop a newly designed double-fixed keratoprosthesis (Seoul-type keratoprosthesis [S-KPro]) and to assess its mechanical stability and biocompatibility. METHODS Twenty-five rabbits were divided into 4 groups by fixation technique, amniotic membrane (AM) implantation, and skirt material. The eyes were studied with the use of slitlamp, light, and electron microscopy. Stress testi...

PURPOSE To describe the clinical course of a patient with a Boston Keratoprosthesis type I who developed a localized posterior pole retinal detachment secondary to a macular hole. OBSERVATIONS A 73-year-old patient with a Boston Keratoprosthesis developed a localized posterior pole retinal detachment secondary to a macular hole. The retinal detachment was repaired with a 23-gauge pars plana v...

We report the histopathology of epithelial overgrowth in the Boston type I keratoprosthesis. The epithelium shows an inconsistent number of layers and basement membrane and goblet cells are absent. Epithelialization of the keratoprosthesis optic would have multiple advantages, but the limitation of vision makes tolerating the overgrowth difficult.

OBJECTIVE To describe the authors' experience using keratoprosthesis to treat pediatric corneal opacity. DESIGN Nonrandomized, consecutive, retrospective interventional series. PARTICIPANTS Twenty-two eyes of 17 children with opaque corneas as a result of primary congenital disease and or previous failed keratoplasty. METHODS A retrospective review of pediatric patients with a history of ...

Boston Keratoprosthesis Type 1 (KPro), an artificial cornea, is a therapeutic option for patients in need of corneal transplantation when the prognosis traditional keratoplasty guarded. Bandage contact lens wear essential post-operative management KPro eyes order to maintain adequate graft hydration, and minimize risk adverse complications. Suitable bandage selection imperative preserve keratop...

A 70-year-old patient who underwent uneventful primary implantation of Auro K Pro (a Type I Boston Keratoprosthesis-based device), developed infiltrates in the deep stroma of the carrier corneal graft and exudates on the optic stem of the keratoprosthesis assembly, 6 weeks postoperatively, which subsequently progressed to endophthalmitis. Vitreous tap was positive for a panfungal polymerase cha...